NCT07080606

Brief Summary

The goal of this clinical trial is to learn if 8 sessions of brief exposure and exercise therapy works to treat Post Traumatic Stress Disorder (PTSD) in adults. This study will also learn if participants think brief exposure and exercise therapy is a good and doable treatment. and The main questions it aims to answer are:

  • Do participants find brief exposure and exercise an acceptable and feasible means of treatment for PTSD?
  • Does brief exposure and exercise decreases of the severity of PTSD symptoms? Participants will:
  • Complete weekly questionnaires for 10-14 weeks.
  • Attend 8 twice weekly exposure therapy and exercise sessions for 4 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 25, 2025

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

July 1, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2026

Completed
Last Updated

April 8, 2026

Status Verified

July 1, 2025

Enrollment Period

8 months

First QC Date

July 1, 2025

Last Update Submit

April 2, 2026

Conditions

Keywords

PTSDExerciseExposure Therapy

Outcome Measures

Primary Outcomes (3)

  • Change in PTSD Checklist for DSM-5 (PCL-5)

    The PCL-5 is a 20-item self-report questionnaire used to assess PTSD symptom severity. Each of the 20 PCL-5 items corresponds to symptoms of PTSD in the DSM-5. Items are rated on a Likert scale from 0 (not at all) to 4 (extremely) based upon how bothered participants are by each symptom. Items on the PCL-5 are summed, resulting in a total score of PTSD symptom severity from 0-80. Scores \>30 indicate probable PTSD.

    Up to 15 weeks.

  • Patient Satisfaction Questionnaire Scores

    Acceptability will be assessed using a patient satisfaction questionnaire. The 5 Items on the patient satisfaction questionnaire are rated on a 4 likert scale with higher scores on the indicating better perceptions of treatment. Total satisfaction of treatment can be obtained by averaging scores across the 5 items.

    Once at end of treatment (up to 9 weeks).

  • Feasibility of the intervention

    Feasibility will be analyzed by examining adherence to the treatment protocol checklist. An average score of 80% treatment adherence for all participants will be used as a threshold to define the feasibility of this intervention.

    4 weeks of treatment following the 3-to 5-week baseline.

Secondary Outcomes (3)

  • Changes in Brief Experiential Avoidance Questionnaire

    Up to 15 weeks

  • Changes in the posttraumatic cognitions inventory-9 (PTCI-9)

    Up to 15 weeks.

  • Changes in the positive and negative valence affect schedule (PANAS)

    Up to 15 weeks.

Study Arms (3)

Brief exposure therapy and exercise 3 week

EXPERIMENTAL

Participants are randomized into the 3 week baseline condition before receiving the exposure therapy and exercise intervention.

Behavioral: Brief exposure therapy and exercise

Brief exposure therapy and exercise 5 week

EXPERIMENTAL

Participants are randomized into the 5 week baseline condition before receiving the exposure therapy and exercise intervention.

Behavioral: Brief exposure therapy and exercise

Brief exposure therapy and exercise 4 week

EXPERIMENTAL

Participants are randomized into the 4 week baseline condition before receiving the exposure therapy and exercise intervention.

Behavioral: Brief exposure therapy and exercise

Interventions

Treatment provided in this study includes an open label brief imaginal exposure therapy for Post Traumatic Stress Disorder (PTSD) and moderate intensity aerobic exercise (i.e., 70-75% max heart rate). Participants all receive 30 minutes of psychotherapy and 25 minutes of exercise.

Also known as: Imaginal Exposure
Brief exposure therapy and exercise 3 weekBrief exposure therapy and exercise 4 weekBrief exposure therapy and exercise 5 week

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Provide informed consent and are willing to participate in therapy sessions twice weekly, which include moderate-intensity aerobic exercise.
  • Participants must be adults aged 18-64 meeting the criteria for PTSD within the past month, who are not currently receiving treatment from other psychotherapy or are on unstable psychiatric medication (i.e., less than four weeks of psychiatric medication).
  • Participants should be able to engage in 25 minutes of moderate-intensity aerobic exercise (i.e., 70-75% of max heart rate).
  • Participants must be able to speak and read English fluently to participate in the current study.

You may not qualify if:

  • Participants who endorse health condition(s) that would prevent moderate exercise.
  • Participants who endorse (i.e., "yes") any items on the Physical Activity Readiness Questionnaire (PARQ) that is not controlled or managed.
  • Participants with any injuries to the lower extremities that may hinder riding an exercise bicycle.
  • Participants currently seeking or undergoing any other trauma-focused psychotherapy treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40506, United States

Location

Related Links

MeSH Terms

Conditions

Combat DisordersStress Disorders, Post-TraumaticMotor Activity

Interventions

ExerciseImplosive Therapy

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaDesensitization, PsychologicBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Jessica Burris, Ph.D.

    University of Kentucky

    STUDY DIRECTOR
  • Shannon Sauer-Zavala, Ph.D.

    University of Kentucky

    STUDY DIRECTOR
  • Troy J.J. Hubert, M.S.

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Acceptability and Feasibility using a Single Case Experimental Design
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Graduate Research Assistant

Study Record Dates

First Submitted

July 1, 2025

First Posted

July 23, 2025

Study Start

June 25, 2025

Primary Completion

March 2, 2026

Study Completion

March 2, 2026

Last Updated

April 8, 2026

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

De-identified data for participants will be shared. This includes data used for primary analysis, a data dictionary defining all variables, a data analytic plan, and R code used for analysis. All IPD will be hosted on OSF and Github.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
IPD and supporting information will be released before the completion of the first participant and stored after the completion of the study. Data analytic plan and analytic code will be stored on github indefinitely.
Access Criteria
The full de-identified dataset will be released by PI to other researchers upon request. The small de-identified dataset of variables used for primary analysis, the data dictionary, data analytic plan, and the R analytic code will be stored on Github and OSF.
More information

Locations